Брой 1/2023, Статии

Хранене при деца с хронични възпалителни чревни заболявания

Публикувана на от admin

Деница Кофинова

Клиника по детска гастроентерология, СБАЛДБ ЕАД „Проф. д-р Иван Митев“, МУ-София

Резюме

През последните десетилетия честотата на хроничните възпалителни заболявания (ХВЧЗ) в детска възраст рязко се увеличава. Натрупват се повече данни за ролята на западния начин на хранене и промяната в микробиома за отключването им. Диетата има и основно място за лечението и поддържането на ремисия при деца с ХВЧЗ. В настоящия обзор се разглежда ролята на храненето за развитието и лечението на болестта на Крон и улцерозен колит при деца.

Ключови думи: хронични възпалителни заболявания, деца, хранене

To access this content, you must purchase Годишен абонамент.

Библиография

  1. Ye Y, Manne S, Treem WR, Bennett D. Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. Inflamm Bowel Dis. 2020;26(4):619-625. 
  2. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720-7.
  3. Sigall-Boneh R, Levine A, Lomer M, Wierdsma N, Allan P, Fiorino G, Gatti S, Jonkers D, Kierkus J, Katsanos KH, Melgar S, Yuksel ES, Whelan K, Wine E, Gerasimidis K. Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]. J Crohns Colitis. 2017;11(12):1407-1419. 
  4. Yao CK, Muir JG, Gibson PR. Review article: insights into colonic protein fermentation, its modulation and potential health implications. Aliment Pharmacol Ther. 2016;43(2):181-96.
  5. Zoetendal EG, de Vos WM. Effect of diet on the intestinal microbiota and its activity. Current opinion in gastroenterology 2014;30:189-95.
  6.  Cani PD, Everard A. Talking microbes: When gut bacteria interact with diet and host organs. Molecular nutrition & food research 2016;60:58-66.
  7. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015;519:92-6.
  8. Swidsinski A, Ung V, Sydora BC, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflammatory bowel diseases 2009;15:359-64.
  9.  Nogueira CM, de Azevedo WM, Dagli ML, et al. Titanium dioxide induced inflammation in the small intestine. World journal of gastroenterology 2012;18:4729-35.
  10.  Werner T, Wagner SJ, Martinez I, et al. Depletion of luminal iron alters the gut microbiota and prevents crohn’s disease-like ileitis. Gut 2011;60:325-33.
  11. Pineton de Chambrun G, Body-Malapel M, Frey-Wagner I, et al. Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal immunology 2014;7:589-601.
  12. Roberts CL, Rushworth SL, Richman E, Rhodes JM. Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of crohn’s disease. Journal of Crohn’s & colitis 2013;7:338-41.
  13. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of crohn’s disease and ulcerative colitis. Gastroenterology 2013;145:970-7.
  14. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The e3n prospective study. The American journal of gastroenterology 2010;105:2195-201.
  15. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of crohn disease in japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of crohn disease in japan. The American journal of clinical nutrition 1996;63:741-5.
  16. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 2004;53:1479-84.
  17. Costea I, Mack DR, Lemaitre RN, et al. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric crohn’s disease.Gastroenterology 2014;146:929-31
  18. Ruemmele FM, Veres G, Kolho KL et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. Journal of Crohn’s and Colitis (2014) 8, 1179–1207
  19. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 2000; 31 (1): 8–15.
  20. Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther 2007; 26 (6): 795–806.
  21. Miele E, Shamir R, Aloi M et al. Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(4):687-708.
  22.  Шентова Р, Янева П, Хаджийски П,  Кофинова Д,  Желев Х. Храни и добавки при деца с хронични възпалителни чревни заболявания. „Профилактика, диагностика и терапия в детско-юношеската възраст“, „От генетичния анализ до здравото дете“. ISBN: 978-619-7063-19-6, Арбилис ООД, 2017: 65-70.
  23. Hearing SD. Refeeding syndrome. BMJ. 2004;328(7445):908-909.
  24.  Shentova-Eneva R, Kofinova D, Hadzhyiski P et al. Anemia in Newly Diagnosed Pediatric Patients with Inflammatory Bowel Disease. Gastroenterology Insights, 2021;12(4):376–383
  25. Penagini F, Dilillo D, Borsani B  et al. Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review. Nutrients. 2016;8(6):334. 
  26. Hanai H, Iida T, Takeuchi K, Watanabe F et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4(12):1502-6.
  27. Suskind DL, Wahbeh G, Burpee T et al. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr. 2013;56(3):277-9
  28. Romano C, Cucchiara S, Barabino A et al. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn’s disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol. 2005;11(45):7118-21.
  29. Xu L, Lochhead P, Ko Y et al. Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780-789.
  30. Piovani D, Danese S, Peyrin-Biroulet L et al. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology. 2019;157(3):647-659.e4. 
  31. Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67(9):1726-1738
  32. Khalili H, Håkansson N, Chan SS et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn’s disease: results from two large prospective cohort studies. Gut. 2020 Sep;69(9):1637-1644.
  33. D’Souza S, Levy E, Mack D et al. Dietary patterns and risk for Crohn’s disease in children. Inflamm Bowel Dis. 2008;14(3):367-73.
  34. Yu Y, Chen KC, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn’s disease: a meta-analysis. World J Pediatr. 2019;15(1):26-36.
  35. Янков И. Ентерално хранене при деца. ISBN: 978-619-189-189-4, Лакс бук ООД, 2022:170.

Адрес за кореспонденция:

д-р Деница Руменова Кофинова, дм

Тел: +359 899 833 867

Email: kofinova@abv.bg